Capital Research Global Investors Abbott Laboratories Transaction History
Capital Research Global Investors
- $463 Billion
- Q3 2024
A detailed history of Capital Research Global Investors transactions in Abbott Laboratories stock. As of the latest transaction made, Capital Research Global Investors holds 53,301,932 shares of ABT stock, worth $6.12 Billion. This represents 1.31% of its overall portfolio holdings.
Number of Shares
53,301,932
Previous 57,237,592
6.88%
Holding current value
$6.12 Billion
Previous $5.95 Billion
2.18%
% of portfolio
1.31%
Previous 1.34%
Shares
29 transactions
Others Institutions Holding ABT
# of Institutions
3,186Shares Held
1.3BCall Options Held
8.74MPut Options Held
8.08M-
Vanguard Group Inc Valley Forge, PA168MShares$19.3 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$15 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$8.8 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$7.54 Billion1.49% of portfolio
-
Geode Capital Management, LLC Boston, MA34.9MShares$4.01 Billion0.33% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $201B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...